Preclinical Research

Biotech appeals to the angels

Biotech appeals to the angels

Venture capital investments in biotechnology and medical device
companies combined to total $4.7 billion (€4.4bn) in 2002, or 22
per cent of all investing, representing the highest proportion in
seven years, according to the MoneyTree...

Go with the flow...

Go with the flow...

A series of new flow cytometry products will soon hit the market
with the announcement yesterday from US companies BD Biosciences
and Molecular Probes that, following a recent license agreement, BD
Biosciences Pharmingen has launched...

A LEAP ahead

A LEAP ahead

Specialists in cellular analysis Cyntellect this week announced the
issuance of a new patent covering the company's Laser Enabled
Analysis and Processing (LEAP) technology platform.

Xenogen in Japan

Xenogen in Japan

SC Biosciences is to be the exclusive distributor of sensitive
tools for drug discovery with the announcement this week that it
will distribute in vivo imaging technology in Japan for US company
Xenogen corporation.

Fund setback for world leader

Fund setback for world leader

Applied Biosystems group, the world's number one maker of
gene-analysing equipment, warned on Tuesday that it would report
lower-than-expected fiscal third-quarter revenue and earnings due
to deteriorating business conditions.

New tool for proteomics

New tool for proteomics

Developer of life science tools Bruker Daltonics has introduced a
new research instrument for proteomics research at the laboratory
science exhibition Pittcon, taking place in the US this week.

Biolog patent

Biolog patent

US company Biolog this week received a patent for its Phenotype
MicroArray technology. The patent, number US 6,472,201, is granted
for comparative phenotypic analysis of two or more microorganisms
using a number of substrates within...

Patent for HCS

Patent for HCS

High Content Screening company Cellomics announced today that the
Canadian Intellectual Property Office has issued Cellomics'
Canadian Patent No. 2,328,194 entitled 'A System for Cell-Based
Screening.'

Ecopia discovery

Ecopia discovery

Canadian drug development company Ecopia BioSciences on Monday
announced that it had filed patent applications for the first two
novel compounds using its proprietary drug discovery platform -
suggesting investments by the company...

Follow us

Products

View more

Webinars